Clinical Trial

Unfolding Severe and Enduring Eating Disorders (U-SEED)

Study acronym: U-SEED
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The main aim of this study is to identify biological and psychological characteristics as risk factors in individuals with severe and enduring eating disorders (SEED). Specifically, the investigators aim to: 1. in a cohort of well-diagnosed eating disorder patients from 2005 followed up in National health registers, explore risk factors at baseline (recorded 2005-2007) for development of later SEED (the registry based cohort). 2. replicate the findings in a new sample of 50 adults with ongoing SEED. Participants will be assessed diagnostically and physically, and asked to fill out questionnaires and leave blood samples (the ongoing SEED sample compared with the register based cohort). 3. in a sample of 50 adults with SEED, explore demographic, biological, clinical, and psychological factors and examine the relation between these factors and symptom severity and functional impairment (the ongoing SEED sample). 4. explore participants perspectives on their symptoms and received care (the ongoing SEED sample).
Trial Details
NCT Number NCT06592963
Lead Sponsor Uppsala University Hospital
Collaborators: The Söderström König Foundation, Forte
Conditions Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Personality Disorders
Enrollment 50 participants
Start Date 2024-06-01
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2024-09-19